The European response to control and manage multi- and extensively drug-resistant Neisseria gonorrhoeae
Open Access
- 5 May 2022
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 27 (18), 2100611-43
- https://doi.org/10.2807/1560-7917.es.2022.27.18.2100611
Abstract
Because cefixime and ceftriaxone resistance in Neisseria gonorrhoeae and gonorrhoea treatment failures were increasing, a response plan to control and manage multidrug-resistant N. gonorrhoeae (MDR-NG) in Europe was published in 2012. The three main areas of the plan were to: (i) strengthen surveillance of antimicrobial resistance (AMR), (ii) implement monitoring of treatment failures and (iii) establish a communication strategy to increase awareness and disseminate AMR results. Since 2012, several additional extensively drug-resistant N. gonorrhoeae (XDR-NG) strains have emerged, and strains with high-level ceftriaxone resistance spread internationally. This prompted an evaluation and review of the 2012 European Centre for Disease Prevention and Control (ECDC) response plan, revealing an overall improvement in many aspects of monitoring AMR in N. gonorrhoeae; however, treatment failure monitoring was a weakness. Accordingly, the plan was updated in 2019 to further support European Union/European Economic Area (EU/EEA) countries in controlling and managing the threat of MDR/XDR-NG in Europe through further strengthening of AMR surveillance and clinical management including treatment failure monitoring. The plan will be assessed biennially to ensure its effectiveness and its value. Along with prevention, diagnostic, treatment and epidemiological surveillance strategies, AMR surveillance is essential for effective control of gonorrhoea.Keywords
This publication has 14 references indexed in Scilit:
- Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018Eurosurveillance, 2018
- Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycinThe Lancet Infectious Diseases, 2018
- Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic surveyThe Lancet Infectious Diseases, 2018
- Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseriagonorrhoeae StrainEmerging Infectious Diseases, 2018
- A systematic review and appraisal of the quality of practice guidelines for the management ofNeisseria gonorrhoeaeinfectionsSexually Transmitted Infections, 2017
- Failure of Dual Antimicrobial Therapy in Treatment of GonorrheaThe New England Journal of Medicine, 2016
- Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and FutureClinical Microbiology Reviews, 2014
- 2012 European guideline on the diagnosis and treatment of gonorrhoea in adultsInternational Journal of STD & AIDS, 2013
- Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeaeExpert Review of Anti-infective Therapy, 2009
- Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countriesAmerican Journal of Obstetrics and Gynecology, 1980